65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Titel:
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Auteur:
Schwarze, J.K. Bertels, C. Awada, G. Tijtgat, J. Tuyaerts, S. Cras, L. Vaeyens, F. Vanbinst, A-M. Everaert, H. Michotte, A. Caljon, B. Olsen, C. Janssen, T. Van Dooren, S. Forsyth, R. Duerinck, J. Neyns, B.